|

Dual-target CAR-NK cells Clinical Trials

4 actively recruiting trials

Pipeline

Phase 1: 2Phase 1/2: 2

Top Sponsors

  • Beijing Biotech4

Indications

  • Cancer4
  • Recurrent Glioblastoma2
  • Malignant Glioma2
  • Glioblastoma2
  • Breast Cancer (Advanced/Metastatic)1

Other4 trials

Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC
Phase 1/2
Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC
Phase 1/2
Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Phase 1
Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.